Biotechnology company Regeneron buying 23andMe for $256 million

How did Moody's downgrade affect U.S. markets? What impact will 23andMe sale have on genetic data privacy? Why is Canada Post facing a potential postal strike? How will Trump's tariffs influence U.S. housing market? Why is JPMorgan allowing clients to buy Bitcoin now? What caused the recent dip in Tesla's stock price? How is AI changing job roles according to Indeed CEO? Why are mortgage rates rising above 7%? How will EU-UK post-Brexit reset affect trade?

Biotechnology company Regeneron buying 23andMe for $256 million

bostonherald.com/2025/05/19/regeneron-buying-23andme

By MICHELLE CHAPMAN, Associated Press
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
In March 23andMe said that it was looking to sell “substantially all of its…

This story appeared on bostonherald.com, 2025-05-19 18:44:41.